Lauren

Biography

Mrs. Silvernail has been a member of Nicox’ board of directors since 2017. Ms. Silvernail is the chief financial officer and chief business officer of Revance Therapeutics Inc. Before joining Revance, Ms. Silvernail was the chief financial officer and vice president of corporate development of ISTA Pharmaceuticals, Inc. from 2003 to 2012. Between 1995 and 2003, Ms. Silvernail served in different operational and corporate development roles for Allergan, including vice president of business development. From 1990 to 1994, she was a general partner of Glenwood Ventures and a member of the boards of directors of several Glenwood portfolio companies. Ms. Silvernail began her career at Varian and Bio Rad Laboratories. Ms. Silvernail received a B.A. in biophysics from the University of California, Berkeley, and an M.B.A. from the University of California, Los Angeles. Mrs. Silvernail has been a member of Nicox’ board of directors since 2017. Ms. Silvernail is the chief financial officer and chief business officer of Revance Therapeutics Inc. Before joining Revance, Ms. Silvernail was the chief financial officer and vice president of corporate development of ISTA Pharmaceuticals, Inc. from 2003 to 2012. Between 1995 and 2003, Ms. Silvernail served in different operational and corporate development roles for Allergan, including vice president of business development. From 1990 to 1994, she was a general partner of Glenwood Ventures and a member of the boards of directors of several Glenwood portfolio companies. Ms. Silvernail began her career at Varian and Bio Rad Laboratories. Ms. Silvernail received a B.A. in biophysics from the University of California, Berkeley, and an M.B.A. from the University of California, Los Angeles.

Research Interest

management and research and development operational and corporate development